Pharmaceutical Bio Association Holds Emergency Ethics Committee Meeting... Hearing Procedures for Bionex and Vibozon Pharmaceutics Initiated

[Asia Economy Reporter Kim Ji-hee] The Korea Pharmaceutical and Bio-Pharma Manufacturers Association announced on the 17th that it will hold an emergency Ethics Committee meeting on the 18th in response to recent controversies over the arbitrary manufacturing of pharmaceuticals by some pharmaceutical companies.

The Ministry of Food and Drug Safety recently took provisional suspension of manufacturing and sales as well as recall measures for certain products from Vinex, which arbitrarily changed the dosage and manufacturing method of the main pharmaceutical ingredients, and Vibozone Pharmaceutical, which manufactured pharmaceuticals differently from the approved specifications. Regarding this, the association stated in an official statement on the 12th, "Regardless of the government authorities' actions, we will take firm measures such as referring the matter to the Ethics Committee as soon as possible."

This Ethics Committee meeting is a follow-up measure to the association's position. During the meeting, opinions will be heard from the representatives of Vinex and Vibozone regarding the Ministry of Food and Drug Safety's announcement and investigation details, and submitted materials will be reviewed.

The Ethics Committee plans to take strict action if the controversies over the arbitrary manufacturing of pharmaceuticals raised against the two companies are found to be true.

This content was produced with the assistance of AI translation services.